Eribulin Mesylate
The mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression. [ ]
Term info
Eribulin Mesylate
- 2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one
- B1939 Mesylate
- E7389
- ER-086526
- ERIBULIN MESYLATE
- Eribulin Mesylate
- Halaven
- Halichondrin B Analog
- eribulin mesylate
NCIT_C116978, NCIT_C63923, NCIT_C128784, NCIT_C157711, NCIT_C116977, NCIT_C157712
A drug used to treat metastatic breast cancer in patients who have already been treated with other chemotherapy. It is also being studied in the treatment of other types of cancer. Halaven may block cancer cell growth by stopping cell division. It belongs to the family of drugs called antitubulin agents.
unresectable or metastatic liposarcoma; breast cancer
253128-41-5
C40H59NO11.CH4O3S
CTRP, FDA
Eribulin Mesylate
AV9U0660CW
http://purl.obolibrary.org/obo/NCIT_C96748
http://purl.obolibrary.org/obo/NCIT_C17219
E7389
707389
257773
257773
Eribulin Mesylate
Pharmacologic Substance, Organic Chemical
C2608038
C26644
Term relations
- Vinca-Domain Binding Agent
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Microtubule Process
- Chemical_Or_Drug_Affects_Gene_Product some Tubulin
- Chemical_Or_Drug_Has_Physiologic_Effect some Positive Regulation of Apoptosis
- Chemical_Or_Drug_Has_Physiologic_Effect some Negative Regulation of Cell Cycle